128940.KS
Hanmi Pharm. Co., Ltd.
1W: +1.9%
1M: -12.2%
3M: +22.0%
YTD: -8.5%
1Y: +121.9%
3Y: +105.4%
5Y: +67.6%
₩551,000.00 ($366.24)
+10000.00 (+1.85%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩6.86T ($4.6B)
52W Range214500-647000
Volume75,947
Avg Volume143,398
Beta0.56
Dividend₩250.00
Analyst Ratings
No analyst coverage
Company Info
CEOJae-Hyun Park
Employees2,270
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2010-07-30
Websitehanmipharm.com
14, Wiryeseong-daero
Seoul 05545
KR
Seoul 05545
KR
82 2 410 9114
About Hanmi Pharm. Co., Ltd.
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found